Randox Laboratories: Evidence MultiSTAT

The Evidence MultiSTAT is a fully automated immunoanalyzer that enables on-site simultaneous detection of up to 44 analytes from a single sample across multiple matrices. It requires a small sample volume and generates results in less than 20 minutes.

Simple 2 step process to results
The process from sample entry to results can be completed in 2 simple steps, with minimal room for human error. The process is designed to make set up and analysis as quick, simple and reliable as possible. The MultiSTAT offers a very simple screening solution to those who have no knowledge of laboratory procedures through combining simplicity with cutting-edge innovation. It is this innovative technology that enables the MultiSTAT to be easy to use, yet extremely powerful.

Cartridge based testing – Based on biochip technology
the Evidence MultiSTAT cartridge contains the necessary reagents required for the chemiluminescent reaction to take place incorporated into its wells. This reduces the manual input required compared to traditional methods such as ELISA testing. No other components are required to run patient samples on the Evidence MultiSTAT and sample volumes as little as 200μl is all that is required, ensuring more sample is available for confirmatory testing if needed.

World’s largest toxicology testing menu
offering the most comprehensive drug of abuse screening on the market detecting over 500 drug and drug metabolites from multiple sample types including whole blood, urine and oral fluid. Delivering comprehensive screening for classical, prescription and synthetic drugs the Evidence MultiSTAT consistently delivers accurate results and offers a highly sensitive method of detecting drugs of abuse. Biochip Array Technology has a proven high standard of accuracy with CVs typically <10 pecent and 98 pecent agreement with confirmatory methods.

With significant reinvestment, our research and development lead the way in developing new tests and innovative technology to suit any drug screening needs. Not only providing rapid toxicology screening from one patient sample but improving efficiency within a clinical setting and reduce the strain on services and resources.

Stroke diagnosis and differentiation
The Evidence MultiSTAT also features advanced rapid stroke diagnosis and differentiation ensuring better patient outcomes guaranteeing timely therapeutic intervention. Allowing for faster and accurate diagnostic classification between ischaemic and haemorrhagic stroke.

The Randox Stroke Biochip is a rapid and highly sensitive blood test that will complement and enhance existing CT scanning technology to facilitate accurate classification of stroke patients and improve patient care pathways.